- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/14 - Oxygen atoms
Patent holdings for IPC class C07D 237/14
Total number of patents in this class: 393
10-year publication summary
|
15
|
24
|
20
|
22
|
31
|
19
|
27
|
27
|
16
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FMC Corporation | 845 |
17 |
| Sumitomo Chemical Company, Limited | 9043 |
11 |
| Hoffmann-La Roche Inc. | 3439 |
10 |
| Abbvie Inc. | 1800 |
10 |
| Merck Patent GmbH | 5815 |
9 |
| Syngenta Participations AG | 1904 |
9 |
| Takeda Pharmaceutical Company Limited | 2708 |
9 |
| F. Hoffmann-La Roche AG | 7947 |
8 |
| Bristol-myers Squibb Company | 4880 |
7 |
| Bayer AG | 3325 |
7 |
| Lantheus Medical Imaging, Inc. | 177 |
7 |
| Celgene Quanticel Research, Inc. | 163 |
6 |
| Ottawa Hospital Research Institute | 108 |
6 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
6 |
| University of Ottawa | 215 |
6 |
| Theravance Biopharma R&D IP, LLC | 456 |
6 |
| Calico Life Sciences LLC | 96 |
6 |
| Novartis AG | 10744 |
5 |
| Syngenta Crop Protection AG | 6074 |
5 |
| Centre National de La Recherche Scientifique | 10464 |
5 |
| Other owners | 238 |